Detalhe da pesquisa
1.
Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
Support Care Cancer
; 32(3): 173, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378914
2.
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Jpn J Clin Oncol
; 53(7): 595-603, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017320
3.
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 52(1): 29-38, 2022 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739075
4.
[Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia].
Rinsho Ketsueki
; 63(8): 860-864, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-36058855
5.
[FIP1L1::PDGFRA-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment].
Rinsho Ketsueki
; 63(12): 1648-1652, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-36653138
6.
Pomalidomide-bortezomib-dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMM.
Cancer Sci
; 111(6): 2116-2122, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297407
7.
[Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis during consolidation chemotherapy].
Rinsho Ketsueki
; 61(5): 462-467, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-32507809
8.
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
Acta Haematol
; 141(2): 111-118, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726834
9.
Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
Ann Hematol
; 96(9): 1471-1475, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28634614
10.
Myelodysplastic syndrome with neutrophilic dermatosis successfully treated with azacitidine.
Rinsho Ketsueki
; 58(6): 607-612, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28679990
11.
[Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study].
Rinsho Ketsueki
; 58(11): 2219-2226, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-29212972
12.
Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study.
Cancer Sci
; 107(5): 653-8, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26914369
13.
Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102).
Rinsho Ketsueki
; 57(11): 2311-2318, 2016.
Artigo
em Japonês
| MEDLINE | ID: mdl-27941278
14.
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma.
Acta Haematol
; 134(1): 25-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25871926
15.
[A CASE OF GRANULOCYTIC SARCOMA IN THE BILATERAL URETER].
Nihon Hinyokika Gakkai Zasshi
; 106(3): 194-8, 2015 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-26419078
16.
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Cancer Rep (Hoboken)
; 7(1): e1938, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014499
17.
Follicular lymphoma with secondary central nervous system relapse: a case report and literature review.
Oxf Med Case Reports
; 2023(11): omad118, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033408
18.
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
NPJ Syst Biol Appl
; 8(1): 39, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229495
19.
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Clin Cancer Res
; 28(13): 2753-2761, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046058
20.
[Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department].
Gan To Kagaku Ryoho
; 38(13): 2579-84, 2011 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-22189222